Lion Point Capital, LP
CIK
1643354
Location
NEW YORK, NY
Portfolio Value
Micro
$31,425,124
Diversification
Moderately concentrated
Filing Date
Global Rank
#7,347
/ 8,603
▼ 82
· as of Mar 2026
Top Industry
Biotechnology
94.5%
3Y Alpha vs SPY
+16.4%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+385.6%
SPY
+76.5%
Annualised alpha
+48.5%
Max drawdown
−42.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
35 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
48.4%
−4.1 pts
Top 5
63.3%
−1.1 pts
Top 10
75.5%
+0.6 pts
HHI
2,455
Moderately concentrated−384
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $31,425,124 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
35 positions ·
$31,425,124 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CUE |
Cue Biopharma, Inc.
Healthcare
|
Held | 2,202,854 | $15,199,692 | 48.37% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 4,450 | $1,433,745 | 4.56% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 67,500 | $1,258,200 | 4.00% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Held | 21,400 | $1,026,558 | 3.27% | |
| MIST |
Milestone Pharmaceuticals Inc.
Healthcare
|
Added | 820,000 | $975,800 | 3.11% | |
| GERN |
Geron Corp
Healthcare
|
Held | 578,000 | $861,220 | 2.74% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Held | 36,000 | $840,960 | 2.68% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Held | 128,650 | $770,613 | 2.45% | |
| FENC |
Fennec Pharmaceuticals Inc.
Healthcare
|
Held | 112,434 | $691,469 | 2.20% | |
| BNTC |
Benitec Biopharma Inc.
Healthcare
|
Held | 62,000 | $660,300 | 2.10% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Held | 28,500 | $620,160 | 1.97% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 8,100 | $517,914 | 1.65% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 80,000 | $442,400 | 1.41% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 51,700 | $437,382 | 1.39% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
Held | 5,500 | $417,175 | 1.33% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Held | 465,000 | $407,340 | 1.30% | |
| HUMA |
Humacyte, Inc.
Healthcare
|
Added | 650,000 | $394,550 | 1.26% | |
| VTRS |
Viatris Inc
Healthcare
|
Held | 27,700 | $374,227 | 1.19% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Held | 46,000 | $373,980 | 1.19% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Held | 5,000 | $371,300 | 1.18% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Held | 18,000 | $326,340 | 1.04% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 86,000 | $307,880 | 0.98% | |
| PCRX |
Pacira BioSciences, Inc.
Healthcare
|
Held | 13,500 | $305,100 | 0.97% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 9,100 | $286,650 | 0.91% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 10,500 | $284,445 | 0.91% | |
| MCRB |
Seres Therapeutics, Inc.
Healthcare
|
Held | 31,570 | $280,025 | 0.89% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Held | 19,000 | $264,100 | 0.84% | |
| QURE |
uniQure N.V.
Healthcare
|
Held | 14,700 | $240,345 | 0.76% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
Held | 26,600 | $222,908 | 0.71% | |
| AZTA |
Azenta, Inc.
Healthcare
|
Held | 9,700 | $204,961 | 0.65% | |
| INVA |
Innoviva, Inc.
Healthcare
|
Held | 8,200 | $191,060 | 0.61% | |
| GHRS |
GH Research PLC
Healthcare
|
Held | 10,200 | $143,412 | 0.46% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Held | 5,250 | $123,690 | 0.39% | |
| IPHA |
Innate Pharma SA
Healthcare
|
Held | 81,151 | $103,873 | 0.33% | |
| SPRB |
Spruce Biosciences, Inc.
Healthcare
|
Held | 1,000 | $65,350 | 0.21% |